Pipeline Moves: Novo Nordisk Phase III semaglutide completion bumps approval prospects
The Clinical Trials Arena team also investigate assets in ophthalmology, genitourinary system, immunology and oncology indications.
Merck and Eisai tease results for renal carcinoma treatment
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
AstraZeneca reports positive results from endometrial cancer therapy trial
Abbisko reports updated results from TGCT Phase Ib study
Antabio on quest to tackle antibiotic resistance
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreRole of machine learning tools in early diagnosis of Parkinson’s disease
GlobalData epidemiologists forecast that there are currently over 2.4 million diagnosed prevalent cases of PD in 7MM.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
It’s a match! Connecting patients to clinical trials with AI
Netramark unveils ChatGPT-based clinical trial de-risking technology
Navigating uncertainty: How Covid-19 has changed the CRO and sponsor dynamic